Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

582 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vedolizumab for the treatment of ulcerative colitis.
Rietdijk ST, D'Haens GR. Rietdijk ST, et al. Expert Rev Clin Pharmacol. 2014 Jul;7(4):423-30. doi: 10.1586/17512433.2014.911084. Epub 2014 May 6. Expert Rev Clin Pharmacol. 2014. PMID: 24802046 Review.
Next-Generation Therapeutics for IBD.
Löwenberg M, D'Haens G. Löwenberg M, et al. Curr Gastroenterol Rep. 2015 Jun;17(6):21. doi: 10.1007/s11894-015-0444-2. Curr Gastroenterol Rep. 2015. PMID: 26031830 Free PMC article. Review.
Evolving Concepts in Phases I and II Drug Development for Crohn's Disease.
Jairath V, Levesque BG, Vande Casteele N, Khanna R, Mosli M, Hindryckx P, Travis S, Duijvestein M, Rimola J, Panes J, D'Haens G, Sandborn WJ, Feagan BG. Jairath V, et al. J Crohns Colitis. 2017 Feb;11(2):246-255. doi: 10.1093/ecco-jcc/jjw137. Epub 2016 Aug 3. J Crohns Colitis. 2017. PMID: 27487793 Review.
Development of an index to define overall disease severity in IBD.
Siegel CA, Whitman CB, Spiegel BMR, Feagan B, Sands B, Loftus EV Jr, Panaccione R, D'Haens G, Bernstein CN, Gearry R, Ng SC, Mantzaris GJ, Sartor B, Silverberg MS, Riddell R, Koutroubakis IE, O'Morain C, Lakatos PL, McGovern DPB, Halfvarson J, Reinisch W, Rogler G, Kruis W, Tysk C, Schreiber S, Danese S, Sandborn W, Griffiths A, Moum B, Gasche C, Pallone F, Travis S, Panes J, Colombel JF, Hanauer S, Peyrin-Biroulet L. Siegel CA, et al. Gut. 2018 Feb;67(2):244-254. doi: 10.1136/gutjnl-2016-312648. Epub 2016 Oct 25. Gut. 2018. PMID: 27780886
Golimumab for moderate to severe ulcerative colitis.
Strik AS, Berends SE, Mathôt RA, D'Haens GR, Löwenberg M. Strik AS, et al. Expert Rev Gastroenterol Hepatol. 2017 May;11(5):401-406. doi: 10.1080/17474124.2017.1303376. Epub 2017 Mar 9. Expert Rev Gastroenterol Hepatol. 2017. PMID: 28276288 Review.
Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn's disease: report of the OPERA study.
Sandborn WJ, Lee SD, Tarabar D, Louis E, Klopocka M, Klaus J, Reinisch W, Hébuterne X, Park DI, Schreiber S, Nayak S, Ahmad A, Banerjee A, Brown LS, Cataldi F, Gorelick KJ, Cheng JB, Hassan-Zahraee M, Clare R, D'Haens GR. Sandborn WJ, et al. Gut. 2018 Oct;67(10):1824-1835. doi: 10.1136/gutjnl-2016-313457. Epub 2017 Oct 5. Gut. 2018. PMID: 28982740 Free PMC article. Clinical Trial.
582 results